Patents by Inventor Donald E. Nash

Donald E. Nash has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9032964
    Abstract: A scientific computer system with processor capable of recording, storing, and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: May 19, 2015
    Assignee: Neuro Code Teen Holdings; LLC
    Inventors: Eleanor Schuler, James K. Poliner, Donald E. Nash
  • Patent number: 8831738
    Abstract: A method and apparatus for recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. A confounding signal is created for retransmission into the cells of a malignant tumor to damage the cell and cause apoptosis. The invention uses ultra low voltage and current to cause apoptosis.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: September 9, 2014
    Assignee: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner
  • Publication number: 20140228910
    Abstract: A scientific computer system with processor capable of recording, storing, and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
    Type: Application
    Filed: February 18, 2014
    Publication date: August 14, 2014
    Applicant: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor Schuler, James K. Poliner, Donald E. Nash
  • Patent number: 8656930
    Abstract: A scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: February 25, 2014
    Assignee: Neuro-Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, James K. Poliner, Donald E. Nash
  • Patent number: 8315712
    Abstract: A hybrid scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. Confounding electrical signals are stored in a scientific cancer cell signal processor of the computer system. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are re-programmed from cancer cell communication signals.
    Type: Grant
    Filed: April 17, 2009
    Date of Patent: November 20, 2012
    Assignee: Neuro Code Tech Holdings, LLC
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner
  • Publication number: 20110270248
    Abstract: A method and apparatus for recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. A confounding signal is created for retransmission into the cells of a malignant tumor to damage the cell and cause apoptosis. The invention uses ultra low voltage and current to cause apoptosis.
    Type: Application
    Filed: April 17, 2009
    Publication date: November 3, 2011
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner
  • Publication number: 20110130754
    Abstract: A hybrid scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. Confounding electrical signals are stored in a scientific cancer cell signal processor of the computer system. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are re-programmed from cancer cell communication signals.
    Type: Application
    Filed: April 17, 2009
    Publication date: June 2, 2011
    Inventors: Eleanor L. Schuler, Donald E. Nash, James K. Poliner
  • Publication number: 20100286689
    Abstract: A scientific computer system with processor capable of recording, storing and reprogramming the natural electrical signals of cancer cells as found in tumors of humans and animals. The reprogramming process is designed to create a confounding electrical signal for retransmission into a malignant tumor to damage or shut-down the cellular internal electrical communication system. Altering the electrical charge on the glycocalyx of the outer cell membrane is also part of the treatment by application of ions. The invention causes cancer cell death as a medical treatment using ultra-low voltage and amperage encoded signals which are reprogrammed from cancer cell communication signals.
    Type: Application
    Filed: January 12, 2009
    Publication date: November 11, 2010
    Inventors: Eleanor L. Schuler, James K. Poliner, Donald E. Nash